CD8 expression in B-cell non-Hodgkin’s lymphomas

By Carulli Giovanni  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 577-579

Springer Publishing Company

Access to resources Recommend Favorite

Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas - dual roles for CD40 and Fas (CD95) ligands modulated by the B cell antigen receptor

By Chaperot L.   Delfau-Larue M.-H.   Jacob M.-C.   Molens J.-P.   Roussel B.   Agrawal S.   Farcet J.-P.   Gressin R.   Sotto J.-J.   Bensa J.-C.   Plumas J.  

Experimental Hematology, Vol. 27, Iss. 7, 1999-07 ,pp. : 1185-1193

Elsevier

Access to resources Recommend Favorite

Analysis of CD80 and CD86 Expression on Peripheral Blood B Lymphocytes Reveals Increased Expression of CD86 in Lupus Patients

By Folzenlogen D.   Hofer M.F.   Leung D.Y.M.   Freed J.H.   Newell M.K.  

Clinical Immunology, Vol. 83, Iss. 3, 1997-06 ,pp. : 199-204

Academic Press

Access to resources Recommend Favorite

Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells

By Habib-Agahi Mojtaba   Phan Thanh T.   Searle Peter F.  

International Immunology, Vol. 19, Iss. 12, 2007-12 ,pp. : 1383-1394

Oxford University Press

Access to resources Recommend Favorite

Use of CFSE to Monitor Ex Vivo Regulatory T-cell Suppression of CD4+ and CD8+ T-cell Proliferation within Unseparated Mononuclear Cells from Malignant and Non-Malignant Human Lymph Node Biopsies

By Hilchey Shannon   Bernstein Steven  

Immunological Investigations, Vol. 36, Iss. 5-6, 2007-09 ,pp. : 629-648

Informa Healthcare

Access to resources Recommend Favorite